Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
2000 1
2003 1
2004 1
2005 2
2006 4
2007 2
2008 1
2012 2
2013 4
2014 3
2015 2
2016 3
2017 4
2018 6
2019 19
2020 27225
2021 54453
2022 22385
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

92,959 results
Results by year
Filters applied: . Clear all
Page 1
Nitric-oxide enriched plasma-activated water inactivates 229E coronavirus and alters antiviral response genes in human lung host cells.
Kaushik NK, Bhartiya P, Kaushik N, Shin Y, Nguyen LN, Park JS, Kim D, Choi EH. Kaushik NK, et al. Bioact Mater. 2023 Jan;19:569-580. doi: 10.1016/j.bioactmat.2022.05.005. Epub 2022 May 8. Bioact Mater. 2023. PMID: 35574062 Free PMC article.
The ongoing pandemic caused by the novel coronavirus, SARS-CoV-2, is influencing global health. Moreover, there is a major threat of future coronaviruses affecting the entire world in a similar, or even more dreadful, manner. ...To determine these effe …
The ongoing pandemic caused by the novel coronavirus, SARS-CoV-2, is influencing global health. Moreover, there …
Privacy-preserving COVID-19 contact tracing solution based on blockchain.
Liu M, Zhang Z, Chai W, Wang B. Liu M, et al. Comput Stand Interfaces. 2023 Jan;83:103643. doi: 10.1016/j.csi.2022.103643. Epub 2022 Apr 4. Comput Stand Interfaces. 2023. PMID: 35400843 Free PMC article.
The COVID-19 pandemic has severely affected daily life and caused a great loss to the global economy. ...It shows that our solution can actually preserve the full-fledged privacy protection property with a lower computational cost....
The COVID-19 pandemic has severely affected daily life and caused a great loss to the global economy. ...It shows that our sol …
Assessment of the relationship between COVID-19 risk perception and vaccine acceptance: a cross-sectional study in Jordan.
Nusair MB, Arabyat R, Khasawneh R, Al-Azzam S, Nusir AT, Alhayek MY. Nusair MB, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2017734. doi: 10.1080/21645515.2021.2017734. Epub 2022 Jan 18. Hum Vaccin Immunother. 2022. PMID: 35377830 Free PMC article.
This study aimed to investigate the factors impacting the rates of COVID-19 vaccine acceptance in Jordan, in addition to examining the relationship between COVID-19 risk perception and vaccine acceptance among the Jordanian populat …
This study aimed to investigate the factors impacting the rates of COVID-19 vaccine acceptance in Jordan, in addition t …
Estimating the size of "anti-vax" and vaccine hesitant populations in the US, UK, and Canada: comparative latent class modeling of vaccine attitudes.
Gravelle TB, Phillips JB, Reifler J, Scotto TJ. Gravelle TB, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2008214. doi: 10.1080/21645515.2021.2008214. Epub 2022 Mar 29. Hum Vaccin Immunother. 2022. PMID: 35349385 Free PMC article.
Vaccine hesitancy is a significant impediment to global efforts to vaccinate against the SARS-CoV-2 virus at levels that generate herd immunity. In this article, we show the utility of an inductive approach - latent class analysis (LCA) - that allows us to ch …
Vaccine hesitancy is a significant impediment to global efforts to vaccinate against the SARS-CoV-2 virus at levels tha …
Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.
Behera P, Singh AK, Subba SH, Mc A, Sahu DP, Chandanshive PD, Pradhan SK, Parida SP, Mishra A, Patro BK, Batmanabane G. Behera P, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2034456. doi: 10.1080/21645515.2022.2034456. Epub 2022 Mar 23. Hum Vaccin Immunother. 2022. PMID: 35321625 Free PMC article.
The primary objective of the study was to estimate the effectiveness of Covaxin in preventing breakthrough SARS-CoV-2 infection in healthcare workers (HCWs). ...The sample size was 670 participants (335 pairs). Conditional logistic regression …
The primary objective of the study was to estimate the effectiveness of Covaxin in preventing breakthrough SARS-CoV- …
Should disability-inclusive health be a priority in low-income countries? A case-study from Zimbabwe.
Kuper H, Smythe T, Kujinga T, Chivandire G, Rusakaniko S. Kuper H, et al. Glob Health Action. 2022 Dec 31;15(1):2032929. doi: 10.1080/16549716.2022.2032929. Glob Health Action. 2022. PMID: 35289734 Free PMC article.
However, it will require financial investment which is challenging as the needs of people with disabilities are set against a background of widespread health systems failures in Zimbabwe, exacerbated by the COVID-19 pandemic. Zimbabwe currently faces an epidemic of …
However, it will require financial investment which is challenging as the needs of people with disabilities are set against a background of …
Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population.
Tawinprai K, Siripongboonsitti T, Porntharukchareon T, Dechates B, Monprach H, Sornsamdang G, Wittayasak K, Soonklang K, Mahanonda N. Tawinprai K, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2035573. doi: 10.1080/21645515.2022.2035573. Epub 2022 Mar 3. Hum Vaccin Immunother. 2022. PMID: 35240945 Free PMC article.
METHODS: This was a single-center, prospective cohort study at Chulabhorn Hospital, Bangkok, Thailand. Individuals 18 years or older who were negative for anti-SARS-CoV-2 antibody were eligible. Anti- receptor-binding domain antibody concentrations were teste …
METHODS: This was a single-center, prospective cohort study at Chulabhorn Hospital, Bangkok, Thailand. Individuals 18 years or older who wer …
Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia.
Dar-Odeh N, Abu-Hammad O, Qasem F, Jambi S, Alhodhodi A, Othman A, Abu-Hammad A, Al-Shorman H, Ryalat S, Abu-Hammad S. Dar-Odeh N, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2039017. doi: 10.1080/21645515.2022.2039017. Epub 2022 Mar 3. Hum Vaccin Immunother. 2022. PMID: 35240939 Free PMC article.
Assessment of safety of COVID-19 vaccines is an ongoing process. This study aims to explore long-term adverse events reported by physicians and dentists who received at least two COVID-19 vaccine doses. ...Less than 20% of COVID-19
Assessment of safety of COVID-19 vaccines is an ongoing process. This study aims to explore long-term adverse events re
Hashtag as a new weapon to resist the COVID-19 vaccination policy: a qualitative study of the anti-vaccine movement in Brazil, USA, and Indonesia.
Khadafi R, Nurmandi A, Qodir Z, Misran. Khadafi R, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2042135. doi: 10.1080/21645515.2022.2042135. Epub 2022 Mar 3. Hum Vaccin Immunother. 2022. PMID: 35240923 Free PMC article.
Third, which narrative dominates the use of Hashtag in each of the three countries? According to the findings of this study, in Brazil, 69.2% of Twitter Hashtag associated to the COVID-19 vaccination were negative, compared to 59.4% in the USA and 62.8 …
Third, which narrative dominates the use of Hashtag in each of the three countries? According to the findings of this study, in Brazil, 69. …
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
Etemadifar M, Abhari AP, Nouri H, Sigari AA, Piran Daliyeh SM, Maracy MR, Salari M, Maleki S, Sedaghat N. Etemadifar M, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2041945. doi: 10.1080/21645515.2022.2041945. Epub 2022 Feb 24. Hum Vaccin Immunother. 2022. PMID: 35201963 Free PMC article.
To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were interviewed. 16.2% of the vaccinated pwMS reported at least one neurological symptom in t …
To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 51 …
92,959 results
You have reached the last available page of results. Please see the User Guide for more information.